WAVE Life Sciences (WVE) Misses Q4 EPS by 6c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.47), $0.06 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $7.06 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Lennar Corp. (LEN) Misses Q2 EPS by 1c